NYSE:TFX - Teleflex Stock Price, Price Target & More

$269.12 +4.63 (+1.75 %)
(As of 04/26/2018 04:00 PM ET)
Previous Close$264.49
Today's Range$264.52 - $269.95
52-Week Range$191.40 - $288.78
Volume185,324 shs
Average Volume306,243 shs
Market Capitalization$11.86 billion
P/E Ratio31.49
Dividend Yield0.52%
Beta1.18

About Teleflex (NYSE:TFX)

Teleflex logoTeleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease. The company also provides interventional access products that are used in dialysis, oncology, and critical care therapies; and cardiac care products, such as diagnostic and intra-aortic balloon catheters, and capital equipment. In addition, it offers anesthesia products, such as pain management products for use in surgical and obstetric procedures; airway management products and related devices for use in pre-hospital emergency and hospital settings; and other pre-hospital emergency products. Further, the company offers surgical products, including Weck Ligation Systems, Weck EFx Fascial Closure Systems, Percutaneous Surgical Systems, Weck Vista bladeless access ports, Deknatel sutures, and Pilling and Kmedic surgical instruments; products for use in acute care settings for diagnostic and therapeutic procedures, and in general and specialty surgical applications; and single-use respiratory, urology, and interventional urology products. Additionally, it provides devices and instruments for other medical device manufacturers, such as custom-engineered extrusions, diagnostic and interventional catheters, balloon sheath/dilator sets and kits, sutures, performance fibers, and bioresorbable resins and fibers. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

Receive TFX News and Ratings via Email

Sign-up to receive the latest news and ratings for TFX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:TFX
CUSIP87936910
Phone610-225-6800

Debt

Debt-to-Equity Ratio0.89%
Current Ratio2.33%
Quick Ratio1.51%

Price-To-Earnings

Trailing P/E Ratio31.49
Forward P/E Ratio27.86
P/E Growth1.95

Sales & Book Value

Annual Sales$2.15 billion
Price / Sales5.65
Cash Flow$12.4708 per share
Price / Cash21.58
Book Value$53.95 per share
Price / Book4.99

Profitability

EPS (Most Recent Fiscal Year)$8.40
Net Income$152.53 million
Net Margins7.11%
Return on Equity16.46%
Return on Assets6.97%

Miscellaneous

Employees14,400
Outstanding Shares45,050,000

How to Become a New Pot Stock Millionaire

Teleflex (NYSE:TFX) Frequently Asked Questions

What is Teleflex's stock symbol?

Teleflex trades on the New York Stock Exchange (NYSE) under the ticker symbol "TFX."

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Thursday, February 22nd. Investors of record on Friday, March 2nd will be paid a dividend of $0.34 per share on Thursday, March 15th. This represents a $1.36 dividend on an annualized basis and a yield of 0.51%. The ex-dividend date is Thursday, March 1st. View Teleflex's Dividend History.

How were Teleflex's earnings last quarter?

Teleflex (NYSE:TFX) announced its earnings results on Thursday, February, 22nd. The medical technology company reported $2.44 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $2.40 by $0.04. The medical technology company had revenue of $595.10 million for the quarter, compared to analyst estimates of $601.17 million. Teleflex had a net margin of 7.11% and a return on equity of 16.46%. Teleflex's revenue was up 15.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.13 earnings per share. View Teleflex's Earnings History.

When is Teleflex's next earnings date?

Teleflex is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for Teleflex.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex updated its FY18 earnings guidance on Thursday, February, 22nd. The company provided earnings per share (EPS) guidance of $9.55-9.75 for the period, compared to the Thomson Reuters consensus estimate of $9.64.

What price target have analysts set for TFX?

10 analysts have issued 12 month target prices for Teleflex's shares. Their predictions range from $251.00 to $300.00. On average, they anticipate Teleflex's share price to reach $280.6667 in the next year. View Analyst Ratings for Teleflex.

What are Wall Street analysts saying about Teleflex stock?

Here are some recent quotes from research analysts about Teleflex stock:
  • 1. According to Zacks Investment Research, "Teleflex Inc. designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company offers its products to hospitals and healthcare providers through its direct sales force and distributors. Teleflex was founded in 1943 and is headquartered in Wayne, Pennsylvania. " (10/4/2017)
  • 2. Barclays analysts commented, "XLRS Progressing Slowly with Some Uncertainty. Although top-line safety data from 12 patients in the Phase I/II XLRS dose escalation study did not reveal SAEs and moderate ocular inflammation was considered manageable, the combination of inter-patient and test variability has affected the ability to determine a therapeutic effect. As a result, AGTC plans to expand enrollment and follow the new patients for at least six months." (9/12/2017)
  • 3. Needham & Company LLC analysts commented, "TFX announced it is acquiring NeoTract for $725M of cash upfront and up to another $375M of revenue-based milestone payments. NeoTract has an innovative treatment for benign prostatic hyperplasia (BPH) called UroLift which offers a number of advantages to competing BPH procedures. The BPH market is large and underpenetrated with potential to reach $30B+ worldwide. TFX expects the deal to be accretive to its revenue growth, margins, and EPS by 2019." (9/5/2017)

Who are some of Teleflex's key competitors?

Who are Teleflex's key executives?

Teleflex's management team includes the folowing people:
  • Mr. Benson F. Smith, Chairman (Age 70)
  • Mr. Liam J. Kelly, Pres & CEO (Age 51)
  • Mr. Thomas E. Powell, Exec. VP & CFO (Age 56)
  • Mr. James J. Leyden, VP, Gen. Counsel & Sec. (Age 51)
  • Mr. Cameron P. Hicks, VP of Global HR (Age 53)

Has Teleflex been receiving favorable news coverage?

News coverage about TFX stock has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Teleflex earned a daily sentiment score of 0.13 on Accern's scale. They also assigned press coverage about the medical technology company an impact score of 47.06 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of Teleflex?

Shares of TFX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Teleflex's stock price today?

One share of TFX stock can currently be purchased for approximately $269.12.

How big of a company is Teleflex?

Teleflex has a market capitalization of $11.86 billion and generates $2.15 billion in revenue each year. The medical technology company earns $152.53 million in net income (profit) each year or $8.40 on an earnings per share basis. Teleflex employs 14,400 workers across the globe.

How can I contact Teleflex?

Teleflex's mailing address is 550 E SWEDESFORD RD, WAYNE PA, 19087. The medical technology company can be reached via phone at 610-225-6800 or via email at [email protected]


MarketBeat Community Rating for Teleflex (TFX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  263 (Vote Outperform)
Underperform Votes:  274 (Vote Underperform)
Total Votes:  537
MarketBeat's community ratings are surveys of what our community members think about Teleflex and other stocks. Vote "Outperform" if you believe TFX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TFX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Teleflex (NYSE:TFX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for Teleflex in the last 12 months. Their average twelve-month price target is $280.6667, suggesting that the stock has a possible upside of 4.29%. The high price target for TFX is $300.00 and the low price target for TFX is $251.00. There are currently 4 hold ratings and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.602.672.672.88
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $280.6667$283.6250$279.3750$260.1429
Price Target Upside: 4.29% upside15.29% upside2.59% upside7.60% upside

Teleflex (NYSE:TFX) Consensus Price Target History

Price Target History for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2018Goldman SachsInitiated CoverageNeutral -> Neutral$257.00LowView Rating Details
2/23/2018Leerink SwannLower Price TargetOutperform -> Outperform$321.00 -> $300.00HighView Rating Details
1/18/2018StephensReiterated RatingBuy$300.00HighView Rating Details
11/14/2017Deutsche BankDowngradeBuy -> Hold$251.00N/AView Rating Details
11/10/2017Piper JaffrayInitiated CoverageOverweight -> Overweight$295.00N/AView Rating Details
11/3/2017Morgan StanleyBoost Price TargetEqual Weight$274.00 -> $290.00N/AView Rating Details
11/3/2017Jefferies GroupBoost Price TargetBuy$270.00 -> $295.00N/AView Rating Details
11/3/2017Needham & Company LLCBoost Price TargetBuy -> Buy$237.00 -> $285.00N/AView Rating Details
9/12/2017BarclaysReiterated RatingOverweight$230.00 -> $253.00LowView Rating Details
9/6/2017KeyCorpReiterated RatingHoldHighView Rating Details
6/1/2016Raymond JamesUpgradeOutperform -> Strong-BuyN/AView Rating Details
4/28/2016Brean CapitalReiterated RatingBuy$157.00 -> $168.00N/AView Rating Details
(Data available from 4/26/2016 forward)

Earnings

Teleflex (NYSE:TFX) Earnings History and Estimates Chart

Earnings by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Earnings Estimates

2018 EPS Consensus Estimate: $9.60
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$1.93$1.95$1.94
Q2 20184$2.31$2.45$2.40
Q3 20184$2.43$2.54$2.48
Q4 20184$2.67$2.87$2.78

Teleflex (NYSE TFX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018$2.01N/AView Earnings Details
2/22/2018Q4 2017$2.40$2.44$601.17 million$595.10 millionViewListenView Earnings Details
11/2/2017Q3 2017$2.01$2.12$522.94 million$534.70 millionViewN/AView Earnings Details
8/3/2017Q2 2017$1.91$2.04$518.98 million$528.60 millionViewListenView Earnings Details
5/4/2017Q1 2017$1.6890$1.80$472.81 million$487.90 millionViewListenView Earnings Details
2/23/2017Q416$2.09$2.13$502.64 million$513.90 millionViewListenView Earnings Details
10/27/2016Q316$1.78$1.80$461.80 million$455.60 millionViewListenView Earnings Details
7/28/2016Q216$1.74$1.89$468.40 million$473.60 millionViewListenView Earnings Details
4/28/2016Q116$1.35$1.52$425.37 million$424.90 millionViewListenView Earnings Details
2/25/2016Q415$1.92$2.01$480.88 million$484.50 millionViewListenView Earnings Details
10/29/2015Q315$1.55$1.60$447.61 million$443.70 millionViewListenView Earnings Details
7/30/2015Q215$1.42$1.42$453.09 million$452.00 millionViewListenView Earnings Details
4/30/2015Q115$1.27$1.30$433.44 million$429.40 millionViewListenView Earnings Details
2/20/2015Q414$1.38$1.43$471.42 million$476.01 millionViewListenView Earnings Details
10/29/2014Q314$1.37$1.57$447.93 million$457.20 millionViewListenView Earnings Details
7/30/2014Q214$1.34$1.51$447.81 million$468.21 millionViewListenView Earnings Details
4/30/2014Q114$1.16$1.22$433.20 million$438.50 millionViewListenView Earnings Details
2/21/2014Q413$1.27$1.36$437.06 million$450.50 millionViewListenView Earnings Details
10/30/2013Q313$1.14$1.33$411.93 million$413.80 millionViewListenView Earnings Details
7/31/2013Q2 2013$1.16$1.27$432.18 million$420.10 millionViewListenView Earnings Details
4/30/2013Q1 2013$1.01$1.03$416.20 million$411.90 millionViewListenView Earnings Details
2/21/2013Q4 2012$4.90$4.70$417.28 million$419.00 millionViewListenView Earnings Details
10/31/2012$1.00$1.04ViewN/AView Earnings Details
7/31/2012$1.10$1.23ViewN/AView Earnings Details
5/1/2012$0.97$1.01ViewN/AView Earnings Details
2/23/2012$1.04$1.07ViewN/AView Earnings Details
10/25/2011$0.81$1.03ViewN/AView Earnings Details
7/27/2011$0.88$0.94ViewN/AView Earnings Details
4/26/2011$0.96$0.96ViewN/AView Earnings Details
2/24/2011$0.92$1.00ViewN/AView Earnings Details
10/26/2010Q3 2010$0.97$1.11ViewN/AView Earnings Details
7/22/2010Q2 2010$1.03$1.04ViewN/AView Earnings Details
4/27/2010Q1 2010$0.89$0.90ViewN/AView Earnings Details
2/24/2010Q4 2009$0.99$1.01ViewN/AView Earnings Details
10/27/2009Q3 2009$0.89$0.88ViewN/AView Earnings Details
7/27/2009Q2 2009$0.88$0.96ViewN/AView Earnings Details
4/28/2009Q1 2009$0.66$0.76ViewN/AView Earnings Details
2/25/2009Q4 2008$0.94$1.04ViewN/AView Earnings Details
10/28/2008Q3 2008$0.97$1.11ViewN/AView Earnings Details
7/29/2008Q2 2008$0.92$1.05ViewN/AView Earnings Details
4/29/2008Q1 2008$0.81$0.85ViewN/AView Earnings Details
2/28/2008Q4 2007$0.97$0.71ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Teleflex (NYSE:TFX) Dividend Information

Teleflex pays an annual dividend of $1.36 per share, with a dividend yield of 0.51%. TFX's most recent quarterly dividend payment was Thursday, March 15. Teleflex pays out 16.19% of its earnings out as a dividend.
Most Recent Dividend:3/15/2018
Annual Dividend:$1.36
Dividend Yield:0.51%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:16.19% (Trailing 12 Months of Earnings)
14.08% (Based on This Year's Estimates)
11.96% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE:TFX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2018quarterly$0.340.53%3/1/20183/2/20183/15/2018
11/2/2017quarterly$0.340.53%11/14/201711/15/201712/15/2017
8/3/2017quarterly$0.340.63%8/11/20178/15/20179/15/2017
5/8/2017quarterly$0.340.7%5/11/20175/15/20176/15/2017
2/23/2017quarterly$0.343/1/20173/3/20173/15/2017
10/27/2016quarterly$0.340.98%11/10/201611/15/201612/15/2016
7/28/2016quarterly$0.340.75%8/11/20168/15/20169/15/2016
5/2/2016quarterly$0.345/12/20165/16/20166/15/2016
2/25/2016quarterly$0.340.94%3/2/20163/4/20163/15/2016
10/29/2015quarterly$0.341.02%11/10/201511/13/201512/14/2015
7/30/2015quarterly$0.341.02%8/12/20158/14/20159/14/2015
5/4/2015quarterly$0.341.09%5/12/20155/14/20156/15/2015
2/20/2015quarterly$0.341.13%2/27/20153/3/20153/16/2015
10/29/2014quarterly$0.3411/12/201411/14/201412/15/2014
7/30/2014quarterly$0.341.25%8/13/20148/15/20149/15/2014
5/5/2014quarterly$0.341.31%5/13/20145/15/20146/16/2014
2/21/2014quarterly$0.341.34%2/28/20143/4/20143/14/2014
10/30/2013quarterly$0.341.49%11/13/201311/15/201312/13/2013
7/31/2013quarterly$0.341.72%8/13/20138/15/20139/13/2013
5/3/2013quarterly$0.341.75%5/13/20135/15/20136/14/2013
2/21/2013quarterly$0.341.74%3/1/20133/5/20133/15/2013
(Data available from 1/1/2013 forward)

Insider Trades

Teleflex (NYSE TFX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.56%
Institutional Ownership Percentage: 90.49%
Insider Trading History for Teleflex (NYSE:TFX)
Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Teleflex (NYSE TFX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/23/2018George Babich JrDirectorSell2,500$270.66$676,650.009,358View SEC Filing  
4/16/2018Benson SmithDirectorSell9,331$260.52$2,430,912.1277,498View SEC Filing  
4/9/2018George Babich JrDirectorSell2,500$246.87$617,175.0011,083View SEC Filing  
4/2/2018Benson SmithDirectorSell9,331$251.49$2,346,653.1983,711View SEC Filing  
3/26/2018George Babich JrDirectorSell2,500$254.53$636,325.008,794View SEC Filing  
3/12/2018George Babich JrDirectorSell2,500$268.53$671,325.0011,083View SEC Filing  
2/28/2018John DerenVPSell1,359$255.67$347,455.53View SEC Filing  
2/26/2018George Babich JrDirectorSell2,500$255.61$639,025.008,886View SEC Filing  
2/12/2018George Babich JrDirectorSell2,500$252.57$631,425.0010,259View SEC Filing  
2/1/2018Stephen K M.D. KlaskoDirectorSell200$276.44$55,288.008,080View SEC Filing  
1/29/2018George Babich JrDirectorSell2,500$283.11$707,775.009,581View SEC Filing  
1/16/2018George Babich JrDirectorSell2,500$263.38$658,450.0010,583View SEC Filing  
1/2/2018Stephen K M.D. KlaskoDirectorSell200$248.96$49,792.008,080View SEC Filing  
12/4/2017Benson SmithCEOSell2,000$258.10$516,200.0076,634View SEC Filing  
12/1/2017Stephen K M.D. KlaskoDirectorSell200$265.32$53,064.008,080View SEC Filing  
11/1/2017Stephen K M.D. KlaskoDirectorSell200$237.18$47,436.008,080View SEC Filing  
10/2/2017Stephen K M.D. KlaskoDirectorSell200$241.88$48,376.008,080View SEC Filing  
9/1/2017Stephen K M.D. KlaskoDirectorSell200$211.75$42,350.008,080View SEC Filing  
8/1/2017Stephen K M.D. KlaskoDirectorSell200$208.41$41,682.008,080View SEC Filing  
7/3/2017Stephen K M.D. KlaskoDirectorSell200$208.10$41,620.008,080View SEC Filing  
6/21/2017Gretchen R HaggertyDirectorBuy1,000$203.82$203,820.001,760View SEC Filing  
6/7/2017Stuart A RandleDirectorSell2,500$205.67$514,175.007,532View SEC Filing  
6/1/2017Stephen K M.D. KlaskoDirectorSell200$199.93$39,986.008,080View SEC Filing  
5/15/2017Stephen K M.D. KlaskoDirectorSell5,200$193.56$1,006,512.0012,880View SEC Filing  
5/9/2017John DerenVPSell2,246$194.07$435,881.223,989View SEC Filing  
12/21/2016Jeffrey A GravesDirectorSell5,000$160.57$802,850.0013,022View SEC Filing  
6/6/2016Stuart A RandleDirectorSell797$166.10$132,381.704,592View SEC Filing  
5/16/2016Thomas Anthony KennedyVPSell15,102$160.20$2,419,340.406,990View SEC Filing  
8/20/2015Patricia C BarronDirectorSell1,500$132.74$199,110.007,623View SEC Filing  
12/22/2014Liam KellyEVPSell3,360$117.38$394,396.80View SEC Filing  
12/1/2014George Babich JrDirectorSell5,000$118.20$591,000.00View SEC Filing  
9/5/2013William Roland CookDirectorSell2,696$77.32$208,454.72View SEC Filing  
8/8/2013Patricia BarronDirectorSell4,000$77.66$310,640.005,677View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Teleflex (NYSE TFX) News Headlines

Source:
DateHeadline
Teleflex (TFX) to Release Earnings on ThursdayTeleflex (TFX) to Release Earnings on Thursday
www.americanbankingnews.com - April 26 at 1:56 AM
Insider Selling: Teleflex (TFX) Director Sells 2,500 Shares of StockInsider Selling: Teleflex (TFX) Director Sells 2,500 Shares of Stock
www.americanbankingnews.com - April 24 at 7:32 PM
Teleflex (TFX) vs. Its Rivals Head-To-Head SurveyTeleflex (TFX) vs. Its Rivals Head-To-Head Survey
www.americanbankingnews.com - April 22 at 11:18 AM
Teleflex (TFX) versus Antares Pharma (ATRS) Critical AnalysisTeleflex (TFX) versus Antares Pharma (ATRS) Critical Analysis
www.americanbankingnews.com - April 21 at 7:20 PM
Critical Contrast: Teleflex (TFX) versus Its RivalsCritical Contrast: Teleflex (TFX) versus Its Rivals
www.americanbankingnews.com - April 21 at 3:06 PM
Teleflex Announces First Quarter 2018 Earnings Conference Call InformationTeleflex Announces First Quarter 2018 Earnings Conference Call Information
finance.yahoo.com - April 19 at 9:29 AM
Can Business Services Aid athenahealth's (ATHN) Q1 Earnings?Can Business Services Aid athenahealth's (ATHN) Q1 Earnings?
finance.yahoo.com - April 19 at 9:29 AM
Benson Smith Sells 9,331 Shares of Teleflex Incorporated (TFX) StockBenson Smith Sells 9,331 Shares of Teleflex Incorporated (TFX) Stock
www.americanbankingnews.com - April 17 at 7:11 PM
Medtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization SpheresMedtronic Expands Focus on Interventional Oncology with Its U.S. Launch of OptiSphere(TM) Embolization Spheres
finance.yahoo.com - April 17 at 4:50 PM
Teleflex (TFX) Downgraded by BidaskClubTeleflex (TFX) Downgraded by BidaskClub
www.americanbankingnews.com - April 14 at 8:37 PM
Teleflexs (TFX) Buy Rating Reaffirmed at Jefferies GroupTeleflex's (TFX) Buy Rating Reaffirmed at Jefferies Group
www.americanbankingnews.com - April 13 at 11:43 PM
Teleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.54 MillionTeleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.54 Million
www.americanbankingnews.com - April 13 at 4:31 AM
Edited Transcript of TFX presentation 7-Mar-17 8:25pm GMTEdited Transcript of TFX presentation 7-Mar-17 8:25pm GMT
finance.yahoo.com - April 12 at 10:23 AM
Estimating The Intrinsic Value Of Teleflex Incorporated (NYSE:TFX)Estimating The Intrinsic Value Of Teleflex Incorporated (NYSE:TFX)
finance.yahoo.com - April 12 at 10:23 AM
Teleflex (TFX) Given "Buy" Rating at Jefferies GroupTeleflex (TFX) Given "Buy" Rating at Jefferies Group
www.americanbankingnews.com - April 11 at 7:19 PM
 Brokerages Expect Teleflex Incorporated (TFX) Will Post Earnings of $1.94 Per Share Brokerages Expect Teleflex Incorporated (TFX) Will Post Earnings of $1.94 Per Share
www.americanbankingnews.com - April 11 at 8:23 AM
Teleflex Incorporated (TFX) Receives Consensus Recommendation of "Hold" from BrokeragesTeleflex Incorporated (TFX) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - April 11 at 5:31 AM
Insider Selling: Teleflex Incorporated (TFX) Director Sells 2,500 Shares of StockInsider Selling: Teleflex Incorporated (TFX) Director Sells 2,500 Shares of Stock
www.americanbankingnews.com - April 10 at 7:11 PM
Teleflex (TFX) Stock Rating Reaffirmed by KeyCorpTeleflex (TFX) Stock Rating Reaffirmed by KeyCorp
www.americanbankingnews.com - April 9 at 12:10 PM
Teleflex (TFX) versus Its Peers Critical ComparisonTeleflex (TFX) versus Its Peers Critical Comparison
www.americanbankingnews.com - April 9 at 3:13 AM
Teleflex (TFX) Rating Reiterated by BarclaysTeleflex (TFX) Rating Reiterated by Barclays
www.americanbankingnews.com - April 8 at 10:46 PM
Teleflex (TFX) & The Competition Critical ContrastTeleflex (TFX) & The Competition Critical Contrast
www.americanbankingnews.com - April 7 at 1:27 PM
Teleflex Incorporated (TFX) Director Benson Smith Sells 9,331 SharesTeleflex Incorporated (TFX) Director Benson Smith Sells 9,331 Shares
www.americanbankingnews.com - April 4 at 10:20 PM
Teleflex (TFX) Now Covered by Goldman SachsTeleflex (TFX) Now Covered by Goldman Sachs
www.americanbankingnews.com - April 4 at 8:04 AM
Teleflex (TFX) & Its Peers Critical ReviewTeleflex (TFX) & Its Peers Critical Review
www.americanbankingnews.com - April 1 at 5:38 AM
Teleflex Incorporated (TFX) Director George Babich, Jr. Sells 2,500 SharesTeleflex Incorporated (TFX) Director George Babich, Jr. Sells 2,500 Shares
www.americanbankingnews.com - March 27 at 10:14 PM
Teleflex (TFX) Stock Rating Reaffirmed by StephensTeleflex (TFX) Stock Rating Reaffirmed by Stephens
www.americanbankingnews.com - March 27 at 1:17 PM
Fluidigm (FLDM) vs. Teleflex (TFX) Head-To-Head ContrastFluidigm (FLDM) vs. Teleflex (TFX) Head-To-Head Contrast
www.americanbankingnews.com - March 27 at 9:22 AM
$568.54 Million in Sales Expected for Teleflex Incorporated (TFX) This Quarter$568.54 Million in Sales Expected for Teleflex Incorporated (TFX) This Quarter
www.americanbankingnews.com - March 27 at 7:34 AM
Teleflexs (TFX) "Buy" Rating Reiterated at Leerink SwannTeleflex's (TFX) "Buy" Rating Reiterated at Leerink Swann
www.americanbankingnews.com - March 26 at 3:13 PM
Teleflex Incorporated (TFX) Expected to Post Earnings of $1.94 Per ShareTeleflex Incorporated (TFX) Expected to Post Earnings of $1.94 Per Share
www.americanbankingnews.com - March 25 at 8:49 AM
Edited Transcript of TFX earnings conference call or presentation 22-Feb-18 1:00pm GMTEdited Transcript of TFX earnings conference call or presentation 22-Feb-18 1:00pm GMT
finance.yahoo.com - March 20 at 4:18 PM
Q1 2018 Earnings Estimate for Teleflex Incorporated Issued By William Blair (TFX)Q1 2018 Earnings Estimate for Teleflex Incorporated Issued By William Blair (TFX)
www.americanbankingnews.com - March 20 at 7:46 AM
Analysts’ Recommendations for Haemonetics and Peers in March 2018Analysts’ Recommendations for Haemonetics and Peers in March 2018
finance.yahoo.com - March 19 at 4:20 PM
Teleflex Incorporated (TFX) Given Consensus Rating of "Hold" by AnalystsTeleflex Incorporated (TFX) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - March 17 at 5:35 AM
Teleflex (TFX) Lowered to C+ at TheStreetTeleflex (TFX) Lowered to C+ at TheStreet
www.americanbankingnews.com - March 14 at 2:36 PM
Teleflex to Present at Needham & Company’s 17th Annual Healthcare ConferenceTeleflex to Present at Needham & Company’s 17th Annual Healthcare Conference
finance.yahoo.com - March 13 at 9:49 AM
Teleflex (TFX) Cut to Hold at ValuEngineTeleflex (TFX) Cut to Hold at ValuEngine
www.americanbankingnews.com - March 11 at 8:18 PM
Teleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.96 MillionTeleflex Incorporated (TFX) Expected to Announce Quarterly Sales of $568.96 Million
www.americanbankingnews.com - March 10 at 10:29 AM
Teleflex (TFX) Presents At Raymond James 39th Annual Institutional Investors Conference - SlideshowTeleflex (TFX) Presents At Raymond James 39th Annual Institutional Investors Conference - Slideshow
seekingalpha.com - March 8 at 5:18 PM
Here's Why Teleflex Has Been Losing Ground Since Q4 EarningsHere's Why Teleflex Has Been Losing Ground Since Q4 Earnings
finance.yahoo.com - March 6 at 4:47 PM
Lombard Odier Asset Management Switzerland SA Boosts Position in Teleflex Incorporated (TFX)Lombard Odier Asset Management Switzerland SA Boosts Position in Teleflex Incorporated (TFX)
www.americanbankingnews.com - March 6 at 1:09 PM
Heres Why Teleflex Has Been Losing Ground Since Q4 EarningsHere's Why Teleflex Has Been Losing Ground Since Q4 Earnings
www.zacks.com - March 6 at 9:20 AM
Teleflex to Present at the 28th Annual Oppenheimer Healthcare ConferenceTeleflex to Present at the 28th Annual Oppenheimer Healthcare Conference
finance.yahoo.com - March 6 at 9:20 AM
Teleflex Incorporated (TFX) Shares Bought by Amalgamated BankTeleflex Incorporated (TFX) Shares Bought by Amalgamated Bank
www.americanbankingnews.com - March 5 at 4:22 AM
Allianz Asset Management GmbH Has $38.16 Million Position in Teleflex Incorporated (TFX)Allianz Asset Management GmbH Has $38.16 Million Position in Teleflex Incorporated (TFX)
www.americanbankingnews.com - March 4 at 4:16 AM
Teleflex Incorporated (TFX) Holdings Reduced by Citadel Advisors LLCTeleflex Incorporated (TFX) Holdings Reduced by Citadel Advisors LLC
www.americanbankingnews.com - March 3 at 5:21 AM
Teleflex Incorporated (TFX) Stake Increased by UBS Asset Management Americas Inc.Teleflex Incorporated (TFX) Stake Increased by UBS Asset Management Americas Inc.
www.americanbankingnews.com - March 2 at 7:50 PM
Teleflex Incorporated (TFX) Position Cut by Credit Agricole S ATeleflex Incorporated (TFX) Position Cut by Credit Agricole S A
www.americanbankingnews.com - March 2 at 3:47 PM
Carillon Tower Advisers Inc. Invests $3.01 Million in Teleflex Incorporated (TFX)Carillon Tower Advisers Inc. Invests $3.01 Million in Teleflex Incorporated (TFX)
www.americanbankingnews.com - March 2 at 5:34 AM

SEC Filings

Teleflex (NYSE:TFX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Teleflex (NYSE:TFX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Teleflex (NYSE TFX) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.